Wave Life Sciences (WVE) Operating Leases (2019 - 2025)
Historic Operating Leases for Wave Life Sciences (WVE) over the last 9 years, with Q3 2025 value amounting to $11.4 million.
- Wave Life Sciences' Operating Leases fell 4245.4% to $11.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.4 million, marking a year-over-year decrease of 4245.4%. This contributed to the annual value of $17.8 million for FY2024, which is 3006.61% down from last year.
- According to the latest figures from Q3 2025, Wave Life Sciences' Operating Leases is $11.4 million, which was down 4245.4% from $13.6 million recorded in Q2 2025.
- In the past 5 years, Wave Life Sciences' Operating Leases registered a high of $35.2 million during Q2 2022, and its lowest value of $11.4 million during Q3 2025.
- Its 5-year average for Operating Leases is $24.0 million, with a median of $23.6 million in 2022.
- As far as peak fluctuations go, Wave Life Sciences' Operating Leases soared by 4978.42% in 2022, and later tumbled by 4245.4% in 2025.
- Quarter analysis of 5 years shows Wave Life Sciences' Operating Leases stood at $25.0 million in 2021, then grew by 28.7% to $32.1 million in 2022, then decreased by 20.9% to $25.4 million in 2023, then crashed by 30.07% to $17.8 million in 2024, then tumbled by 35.96% to $11.4 million in 2025.
- Its last three reported values are $11.4 million in Q3 2025, $13.6 million for Q2 2025, and $15.7 million during Q1 2025.